Skip to Main Content
Back to News

Fund Update: RHUMBLINE ADVISERS opened a $6.0M position in $CRSP stock

None

RHUMBLINE ADVISERS has opened a new $6.0M position in $CRSP, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $CRSP.

$CRSP Hedge Fund Activity

We have seen 180 institutional investors add shares of $CRSP stock to their portfolio, and 182 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CRSP Insider Trading Activity

$CRSP insiders have traded $CRSP stock on the open market 23 times in the past 6 months. Of those trades, 5 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $CRSP stock by insiders over the last 6 months:

  • SIMEON GEORGE has made 3 purchases buying 989,812 shares for an estimated $51,499,918 and 0 sales.
  • SAMARTH KULKARNI (Chief Executive Officer) has made 0 purchases and 6 sales selling 61,394 shares for an estimated $3,050,070.
  • DOUGLAS A TRECO purchased 20,000 shares for an estimated $1,140,600
  • JAMES R. KASINGER (General Counsel and Secretary) has made 0 purchases and 5 sales selling 18,693 shares for an estimated $920,052.
  • JOHN GREENE purchased 7,000 shares for an estimated $313,947
  • RAJU PRASAD (Chief Financial Officer) has made 0 purchases and 2 sales selling 5,959 shares for an estimated $247,833.
  • JULIANNE BRUNO (Chief Operating Officer) has made 0 purchases and 4 sales selling 3,435 shares for an estimated $147,300.
  • NAIMISH PATEL (Chief Medical Officer) sold 3,932 shares for an estimated $141,316

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CRSP Analyst Ratings

Wall Street analysts have issued reports on $CRSP in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • HC Wainwright & Co. issued a "Buy" rating on 08/07/2025
  • Chardan Capital issued a "Buy" rating on 08/05/2025
  • B of A Securities issued a "Buy" rating on 07/22/2025
  • Piper Sandler issued a "Overweight" rating on 06/27/2025
  • JMP Securities issued a "Market Outperform" rating on 06/27/2025
  • Needham issued a "Buy" rating on 06/26/2025
  • Citigroup issued a "Buy" rating on 02/18/2025

To track analyst ratings and price targets for $CRSP, check out Quiver Quantitative's $CRSP forecast page.

$CRSP Price Targets

Multiple analysts have issued price targets for $CRSP recently. We have seen 13 analysts offer price targets for $CRSP in the last 6 months, with a median target of $80.0.

Here are some recent targets:

  • Mitchell Kapoor from HC Wainwright & Co. set a target price of $80.0 on 08/07/2025
  • Gena Wang from Barclays set a target price of $56.0 on 08/06/2025
  • Geulah Livshits from Chardan Capital set a target price of $82.0 on 08/05/2025
  • Luca Issi from RBC Capital set a target price of $42.0 on 08/05/2025
  • Geoff Meacham from B of A Securities set a target price of $78.0 on 07/22/2025
  • Gil Blum from Needham set a target price of $81.0 on 07/08/2025
  • Edward Tenthoff from Piper Sandler set a target price of $105.0 on 06/27/2025

Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.

Check out Quiver Quantitative's $CRSP ticker page for more data.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles